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0951-7367 Copyright  2017 Wolte¨Anita Riecher-Rossler and Erich StuderusPurpose of review
So far, only little more than one-third of individuals classified as being at-risk for psychosis have been
shown to actually convert to frank psychosis during follow-up. There have therefore been enormous efforts
to improve the accuracy of predicting this transition. We reviewed the most recent studies in the field with
the aim to clarify whether accuracy of prediction has been improved by the different research endeavors
and what could be done to further improve it, and/or what alternative goals research should pursue.
Recent findings
A total of 56 studies published between May 2015 and December 2016 were included, of which eight
were meta-analyses. New meta-analytical evidence confirms that established instruments for checking
clinical risk criteria have an excellent clinical utility in individuals referred to high-risk services. Within a
such identified group of ultra-high-risk (UHR) individuals, especially Brief Limited Intermittent Psychotic
Symptoms and Attenuated Psychotic Symptoms seem to predict transition. Further assessments should be
performed within the UHR individuals, as risk of transition seems particularly high in those with an even
higher severity of certain symptoms such as suspiciousness or anhedonia, in those with lower global or
social functioning, poor neurocognitive performance or cannabis abuse. Also, electroencephalography,
neuroimaging and blood biomarkers might contribute to improving individual prediction. The most
promising approach certainly is a staged multidomain assessment. Risk calculators to integrate all data for
an individualized prediction are being developed.
Summary
Prediction of psychosis is already possible with an excellent prognostic performance based on clinical
assessments. Recent studies show that this accuracy can be further improved by using multidomain
approaches and modern statistics for individualized prediction. The challenge now is the translation into
the clinic with a broad clinical implementation.
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DOI:10.1097/YCO.0000000000000320Early detection of emerging psychosis has been a
major goal of psychiatric research in the last two
decades. In an earlier retrospective study [1], we had
shown that about 70% of schizophrenic psychoses
do not start with frank psychotic symptoms but
emerge slowly over an average period of 4–5 years,
first with quite unspecific so-called prodromal
symptoms and then with more specific subthres-
hold, so-called ‘attenuated’ psychotic symptoms or
even very short self-limiting psychotic symptoms.
The construct of a clinical high risk (CHR) or at-risk
mental state (ARMS) for psychosis was suggested to
capture this early phase of disease [2]. Increasing
recognition of this concept has led to the introduc-
tion of the ‘Attenuated Psychosis Syndrome’ intoht © 2017 Wolters Kluwe
rs Kluwer Health, Inc. All rights resea ‘condition for further study’ [3].
Research has so far focused on detecting indi-
viduals in this early stage of disease to predict tran-
sition to frank psychosis and at the same time to
offer a therapy for those seeking help.r Health, Inc. All rights reserved.
rved. www.co-psychiatry.com
KEY POINTS
 Identification of individuals at risk and prediction of
transition to psychosis is possible with an excellent
accuracy comparable with other preventive approaches
in medicine.
 Recent studies show that this accuracy might be further
improved by using stepwise multidomain approaches
and modern statistical methods.
 For further improvement of prediction, we need
multicenter studies with larger samples, inclusion of a
broader age range of at-risk individuals and longer
follow-ups.
 Methodology has to be further improved by better
standardization of assessment methods and better
control of intercenter effects. Studies on risk prediction
models should more strictly adhere to current checklists
and guidelines on clinical prediction modeling.
 For translation into the clinic, easy-to-use, stepwise risk
assessment tools and guidelines as well as
individualized prediction calculators should be
developed. More effort has to be put into a broad
clinical implementation.
Table 1. Inclusion and exclusion criteria of studies
Inclusion criteria
1. Only prospective studies with mean follow-up period
12 months or meta-analyses relevant to prediction of
transition
2. Study participants at baseline had to fulfil clearly defined
clinical high risk (HR) criteria for psychosis (see Table 2)
3. Transition to psychosis had to be clearly defined (usually
according to Yung et al. [2]).
4. Transition of 10 participants
Exclusion criteria
1. Therapy studies
Schizophrenia and related disordersAs regards the prediction of transition, two
recent meta-analyses [4,5
&
] have shown that about
37% of those fulfilling current risk criteria develop
psychosis, mainly schizophrenia spectrum disorders,
within 3 years.
This review summarizes more recent studies and
meta-analyses regarding the prediction of conver-
sion to frank psychosis in patientsmeeting clinically
defined at-risk criteria, excluding studies on indi-
viduals with a purely genetic risk. We first look
into studies on predictors from single domains
and then into those with a multidomain approach
and modeling. We aimed at clarifying whether
accuracy of prediction has been improved by the
different research endeavors and what could be
done to further improve it, and/or which alternative
goals research should pursue.METHODS
Articles published from 1 May 2015 until 14 Decem-
ber 2016were systematically searched via thePubMed
database. The following search terms were applied:
‘psychosis and (‘ultra-high risk’ or UHR or ‘clinical
high risk’ or CHR or prodrom or ‘psychosis risk’ or
‘risk of psychosis’ or ‘clinically at high risk’ or ‘at-risk
mental state’ or ARMS or ‘at-risk patients’) and (con-
version or convert or transit or predict) and [‘2015/
05/01’(EDat): ‘2016/12/14’(EDat)]. Furthermore, a
hand-search of relevant journals and reference lists Copyright © 2017 Wolters Kluwer 
210 www.co-psychiatry.comof included articles was performed. Only peer-
reviewed original articles and meta-analyses were
included according to the criteria shown in Table 1
[2].RESULTS
From the mentioned period, 56 studies were
included (Fig. 1). Of these, eight were meta-analyses
[6–7,8
&
,9,10,11
&
–13
&
]. Detailed lists of the included
original studies and meta-analyses are provided
in Supplementary Tables S1 and S2, http://links.
lww.com/YCO/A37, respectively. Figure 2 shows
the predictor domains investigated; 21 studies
developed prediction models from multiple
domains. It is important to note that most predic-
tors were only studied within the group of individ-
uals clinically classified as being at risk.Clinical predictors
Clinical characteristics assessed at baseline had a very
high predictive power. This is especially true for the
fulfillment of predefined clinical risk criteria in indi-
viduals referred to early detection clinics.
Risk criteria
Help-seeking individuals were generally classified as
being at CHR for psychosis-Hif they met at least one of three UHR inclusion
criteria [brief limited intermittent psychotic
symptoms (BLIPS) and/or subthreshold so-called
attenuated psychotic symptoms (APS) and/or
genetic risk and deterioration syndrome (GRD)],- or if they met basic symptom criteria (i.e. subjec-
tive disturbances of cognitive processes and per-
ception) [5
&
].
See also Table 2 [4].
We have recently compared the risk of transition
to psychosis between the different risk groups in aealth, Inc. All rights reserved.
Volume 30  Number 3  May 2017
FIGURE 1. Flow chart of literature search.
Prediction of conversion to psychosis Riecher-Ro¨ssler and Studerusmeta-analysis of 33 independent studies comprising
4227 individuals [11
&
]. Most individuals (85%) had
been included because of APS, 10% because of BLIPS
and 5% solely because of GRD. The risk of transition
was higher in BLIPS than in APS individuals (e.g. 39
versus 19% at 24 months). The group with GRD had
no higher risk of transition than those without Copyright © 2017 Wolters Kluwe
FIGURE 2. Predictor variable domains of included studies. Note
(CHR) individuals previously identified by clinical criteria. Multiple
0951-7367 Copyright  2017 Wolters Kluwer Health, Inc. All rights resesupposed risk. In an earlier meta-analysis, we had
found a conversion rate comparable with UHR
samples at 2 years and an even higher rate after
4 years in the basic symptom group with cognitive
disturbances [5
&
]. Most transitions occur within
2 years and half of these within the first 8 months
[14], but there are also later transitions [15–17].r Health, Inc. All rights reserved.
: Prediction was always performed within Cinical High Risk
domains were tested in many studies.
rved. www.co-psychiatry.com 211
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Prediction of conversion to psychosis Riecher-Ro¨ssler and StuderusInstruments for assessing risk criteria
As the instruments used to check risk criteria might
also influence the accuracy of prediction, we con-
ducted a prognostic accuracy meta-analysis of the
different psychometric interviews used in the field
[13
&
] (see also Table 2 [4]). All instruments showed
an excellent prognostic performance (AUC¼0.89)
with no significant differences between them. How-
ever, although sensitivity was outstanding, speci-
ficity was poor and showed some heterogeneity
between instruments.Current psychopathology
Several studies have additionally examined if a more
detailed assessment of symptomatology within the
group of patients already identified as CHR can
increase the accuracy of prediction. In fact, more
severe positive symptoms [18,19], severity of unusual
thought content, suspiciousness, reduced ideational
richness and difficulty with focus/concentration
[20], physical anhedonia [21] and perceptual disturb-
ance [22]might further increase the risk of transition,
whereas negative symptoms in general [23] or initial
anxiety [24] did not further contribute to prediction.
Disorganized communication seems to be predictive
in children [25] and adolescents [26].
Functioning
In 2016, a meta-analysis of 10 studies found that
converters have moderately lower baseline func-
tioning than nonconverters [6]. More recent studies
confirmed that functioning at baseline is quite a
robust predictor for later transition to psychosis, be
it global [19,27] or social [28] functioning. Although
most studies on functioning have focused on real-
world achievements, one recent study [29] used
a laboratory-based measure. Poor performance on
thismeasure also significantly predicted conversion,
even after adjusting for important confounders.
Substance abuse
Cannabis use has shown to be associated with an
increased risk of psychotic outcomes [30]. Within
the group of UHR individuals, meeting criteria for
current cannabis abuse or dependence was predic-
tive of transition to psychosis, as shown by a meta-
analysis based on five prospective studies [8
&
]. A
more recent study [31] found a history of cannabis
abuse in 58% of UHR individuals, of whom 26%
reported cannabis-induced APS. These individuals
were 4.9 times more likely to convert to psychosis.
Duration of untreated illness
Recent studies imply that at-risk individuals with a
longer duration of untreated prodromal symptoms Copyright © 2017 Wolters Kluwe
0951-7367 Copyright  2017 Wolters Kluwer Health, Inc. All rights resehave a higher conversion rate [19], whereas the
duration of negative or positive symptoms seems
not predictive [18].Recruitment strategies
Recruitment strategies play an important role for the
risk enrichment. In a recent meta-analysis, we could
show the best overall risk enrichment in centers
directing their outreach campaigns tomental health
professionals, whereas intensive campaigns pre-
dominantly targeting the general population
resulted in a higher proportion of self-referrals with
lower risk for psychosis [12
&
]. To overcome this
problem, several authors have suggested a stepwise
enrichment strategy, using different instruments
consecutively [32–34].Sociodemographic predictors
Sex was not found to be predictive of conversion to
psychosis in any included study [19,35–42,43
&
,44–50],
which is in accordance with a recent systematic review
[51].
As regards age, our meta-analysis had shown
lower conversion rates in children and adolescents
[5
&
]. Most recent studies failed to find an association
between baseline age and later transition to psychosis
[18,21,29,35–42,43
&
,44–50,52
&&
],whereasothers found
younger age [19,52
&&
] or older age [16,21,28,53] to be a
risk factor.
Level of education was not found to be predic-
tive [21,38,42,44,47,48,50] except for one study [40]
reporting lower levels of education in converters.
Another study [35] found parental education of
converters to be higher.
Parental socioeconomic status seems not predic-
tive [54]. As regards marital status, results were
contradictory [19,50].Premorbid risk factors
Poor ‘premorbid’ functioning during adolescence
has been reported to increase the risk of transition
in CHR individuals [55]. Early indicators of
enhanced vulnerability and early stressors, which
have been associated with schizophrenia, were
more commonly found in CHR individuals than
in healthy controls, but there were no significant
differences between those who made the transition
and those who did not [50].
Childhood trauma, abuse, stigma and
discrimination
Although earlier studies had found sexual abuse in
childhood to be a predictor of transition in UHRr Health, Inc. All rights reserved.
rved. www.co-psychiatry.com 213
Schizophrenia and related disordersindividuals, recent studies could not confirm this.
Neither was childhood trauma in general predictive
[39,56].
Perceived discrimination during lifetime was
reported to increase the risk of transition in CHR
individuals [56]. The same was true for more per-
ceived harm because of stigma at study intake, even
after adjusting for age, sex, symptoms and function-
ing [36].
Genetic risk
Asmentioned above, individuals qualifying for CHR
because of a combination of genetic risk and
decrease in functioning have a much lower risk of
conversion than those with APS or BLIPS. Thus,
genetic risk does not seem to predict if an individual
converts within a short time.
In 2016, interesting results also came from epi-
genetics, which refers to the interplay between
genes and environment in emerging psychoses. In
a first longitudinal prospective study of genomic
DNA methylation in help-seeking young individ-
uals, it could be shown that conversion to psychosis
was associated with specific methylation changes,
which were significantly different between convert-
ers and nonconverters [43
&
].
In another interesting approach, individuals
with 22q11.2 deletion syndrome, which is charac-
terized by high rates of psychosis, were examined
[57]. At baseline, 25% of study participantsmet UHR
criteria for psychosis. In this group, the transition
rate to frank psychosis was 27% within a mean
interval of 33 months. Interestingly, also in those
not fulfilling risk criteria, the transition rate was
almost 5%. An additional predictor was global func-
tioning at baseline.Neurocognition
In a recent review [58], we found that individuals
with later transition to psychosis show a significantly
worse cognitive performance than those without
later transition in almost all cognitive domains.
In a more recent multicenter study [48], con-
verters had significantly lower attention, working
memory and declarative memory abilities. In a
partially overlapping sample [37], later converters
showed worse global neurocognitive performance
and, more specifically, stronger impairments in IQ,
verbal memory, processing speed, sustained atten-
tion and working memory. Similarly, IQ, processing
speed, learning/memory, working memory and
verbal fluency discriminated converters from non-
converters in another study [46].
Social cognition, in contrast, was not found to
predict transition in the majority of studies after Copyright © 2017 Wolters Kluwer 
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toms; for a meta-analysis, see [7]. A more recent
study [59] detected lower theory of mind abilities
in those with later transition.
In a study on olfactory functioning [47], deficits
in the identification of pleasant, but not unpleasant
and neutral odors were a risk factor for conversion
to psychosis.
Several recent studies have incorporated cogni-
tive performance into multivariable risk prediction
models [16,28,46,48,52
&&
,53]. Most of them confirm
that cognitive variables contain nonredundant pre-
dictive information that can improve the prediction
of psychosis although their predictive power is lower
than that of psychopathological variables.Neurophysiology (EEG)
A review and meta-analysis in 2015 [60] concluded
that mismatch negativity so far is the most promis-
ing EEG parameter for predicting transition to psy-
chosis in CHRpatients.More recently, we [38] found
that psychosis could be predicted with relatively
high accuracy from the current source density but
not the lagged phase synchronicity of g and b oscil-
lations at rest. The cortical areas most strongly con-
tributing to the prediction were similar to those that
have been found to be important for the generation
of the P300 event-related potential component,
which had been identified as a predictor of psychosis
in an earlier study [61]. Other parameters could not
be demonstrated to be significantly associated with
later transition to psychosis [45].Neuroimaging
Neuroimaging studies comparing baseline measure-
ments of UHR individuals who later made the con-
version to psychosis to those who did not reported
differences in the volume of the medial temporal
lobe, prefrontal and cingulate cortex, in the integrity
of white matter pathways, and in glutamate levels in
the caudate nuclei, aswell as differences in activation
in the prefrontal cortex, medial temporal lobe, mid-
brain and caudate (for a recent review, see [62]).
Recent studies have shown reduced functional
connectivity in ARMS individuals, especially in
those with later transition to psychosis [63,64]. Dis-
connectivity correlated with symptom severity [64].
Although in a first era of neuroimaging studies
only average differences between groups were
described, the clinical need to make predictions
for individuals has recently been taken into account.
Pattern recognition methods or machine-learning
methods have been used, which allow for individual
classification [62,65
&
]. In one of the first of suchHealth, Inc. All rights reserved.
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outcomes across two centers with an accuracy of
80% [65
&
].Blood biomarkers, neuroinflammation, stress
and stress hormones
As increasing evidence indicates an inflammatory
contribution to some forms of psychosis, neuroin-
flammation biomarkers were also tested for their
potential to predict transition. In fact, there is pre-
liminary evidence that elevation of the baseline
plasma levels of certain markers of inflammation,
oxidative stress and dysregulation of the hypothala-
mic-pituitary-adrenal (HPA) axis may be associated
with transition [66], and there were first attempts to
develop blood biomarker assays to increase the
accuracy of prediction [67]. In the period under
study, a 22-analyte molecular biomarker panel
was developed in a multistage approach [68
&&
]. It
achieved an excellent predictive performance for
transition, which could be further improved by
integrating a positive symptom score [68
&&
].
Stress is thought to play a role in the risk of
developing psychosis. Well in line with this, more
stressful life events at intake and more perceived
stress in ARMS were predictive for later transition in
a recent study [69].
As regards stress-related biomarkers, not only
cortisol and the HPA axis were recently tested but
also prolactin and the hypothalamic-pituitary-
gonadal (HPG) axis. Baseline cortisol levels, although
elevated in CHR as compared with controls, do not
seem to predict conversion, as a recentmeta-analysis
showed [9]. Regarding the HPG axis, gonadal dys-
functionwithhypoestrogenismhasbeen reported for
a long time inwomenwith schizophrenic psychoses,
evenwhen unmedicated [70]. There is now emerging
evidence that thismightbedue to increasedprolactin
levels, which can suppress estrogen production and
have recently been shown not only in antipsychotic-
naive first-episode patients, but also in at-riskmental
state patients [70]. In a study examining different
stress-related biomarkers, among others cortisol and
prolactin, only high prolactin levels seemed to pre-
dict transition [69]. This would be well in line with
the potential of elevated prolactin to increase dopa-
mine release in a feedback mechanism and thereby
trigger the outbreak of psychosis, as suggested by
Riecher-Ro¨ssler [70].Other predictors
Although we excluded therapy studies, some studies
did allow antipsychotic treatment. In these studies,
sensitivity of prediction decreased [13
&
]. Copyright © 2017 Wolters Kluwe
0951-7367 Copyright  2017 Wolters Kluwer Health, Inc. All rights reseFinally, a small study reported a higher con-
sumption of omega-6 fatty acids to be associated
with an increased risk of transition [44].Multidomain models for risk prediction
Cannon et al. [52
&&
] recently developed the first
individualized psychosis risk calculator based on a
big multicenter cohort. The calculator has been
implemented as a web-based tool (http://riskcalc.
org:3838/napls/) and assigns a 2-year probability of
conversion to individuals based on their scoring on
nine variables, which have to be assessed by skilled
raters using specific instruments. In their own
cohort, higher levels of unusual thought content
and suspiciousness, greater decline in social func-
tioning, lower verbal learning andmemory perform-
ance, slower speed of processing and younger age at
baseline each significantly increased the risk of con-
version. This calculator was also found to provide a
solid estimation of conversion outcome in a vali-
dation study [53].
In adolescents, Cornblatt et al. [16] showed dis-
organized communication, suspiciousness, verbal
memory deficits and decline in social functioning
during follow-up to predict transition. However,
Addington et al. [28] found a poor discrimination
of this model in an external validation with a
slightly older sample. They developed a model
finally containing unusual thought content, disor-
ganized communication, baseline social function-
ing, verbal fluency, verbal memory, processing
speed and age as predictors. In a study solely based
on sociodemographic and clinical variables [42],
transition was associated with observed blunted
affect, subjective complaints of impaired motor
function, beliefs about social marginalization,
decline in social functioning and distress associated
with suspiciousness. In a model based on clinical
and neurocognitive variables, the combination of
positive/negative symptom severity and IQ best pre-
dicted psychosis [46].
Several studies also appliedmultidomainmodels
to test for independent associations of variables of
interest with transition to psychosis. Significant
associations were found for stigma stress [36], low
functional capacity [29], physical anhedonia [21],
deficits in olfactory identification [47], low neuro-
cognitive performance [48], auditory and visual per-
ceptual abnormalities [49] and history of cannabis-
inducedAPS [31], butnot forpositive schizotypy [21],
childhood trauma [39] or childhood adversity [71].
In a small study apart from clinical predictors,
blood biomarkers and EEG measures were also inte-
grated [45]. Although oxidative stress markers and
EEG were not predictive, this was the case for ar Health, Inc. All rights reserved.
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tioning, history of drug use and the biomarkers
omega-3 and nervonic acid.
Finally, Schmidt et al. [10] performed statistical
simulations based on published prediction models.
They found the highest positive predictive value
with a sequential three-stage testing strategy of
CHR, using clinical and electroencephalography
data first, then structural MRI and blood markers
in a last step.Declining transition rates
The rate of transition in UHR samples has declined
in recent cohorts. This seems to have several causes
such as different clinical intake characteristics, (i.e. a
smaller array of attenuated psychosis symptoms, less
conceptual disorganization and less trait risk factors)
[72], different recruitment strategies [12
&
,73] as well
as earlier referral and intervention [74], possibly
earlier antipsychotic treatment.CONCLUSIONS
Recent studies confirmed that identification of
individuals at risk and prediction of transition to
psychosis is possible with an excellent overall prog-
nostic performance, comparable with other preven-
tive approaches in medicine [13
&
,52
&&
]. The few
clinical instruments used worldwide obviously have
a very high sensitivity, accompanied by a moderate
specificity [13
&
], which is what is really wanted in a
first clinical step in order to not exclude anybody at
risk. In a stepwise approach, this most important
basic clinical assessment can and should be followed
by the assessment of other domains and amultilevel
modeling of the risk.
The period under review has shown that we
should integrate even more domains to address
the complex interactions between neurobiological
and environmental factors into prediction models.
A thorough clinical assessment, including not only
symptomatology but also functioning, still seems to
have the best predictive power. Additional promis-
ing domains are neurocognition, neuroimaging,
neurophysiology and – quite recently – also the
development of blood biomarkers. Interesting con-
tributions might also come from epigenetics. The
familial risk of an individual rather seems to be a
long-term risk factor, not influencing transition
rates in the studies conducted so far, which had
relatively short follow-up durations.
There were also important methodological
achievements in the period under study. Thus,
large meta-analyses on crucial clinical questions
were conducted and large multicenter studies such Copyright © 2017 Wolters Kluwer 
216 www.co-psychiatry.comas EU-GEI [75], NAPLS [76], PRONIA (https://
www.pronia.eu/) and PSYSCAN (http://www.
psyscan.eu/) are pursued with standardization of
assessmentmethodologywithin these large consortia.
Last but not least, new promising methods for
data analyses such as machine learning were imple-
mented, which in a first step allowed individualized
risk prediction based on neuroimaging [65
&
], neuro-
cognitive [77] and clinical data [27]. This method
could also be applied on multidomain data in the
future. A very important achievement certainly also
is the development and validation of an individu-
alized risk prediction tool based on clinical and
neurocognitive data [52
&&
,53].
There are also some limitations of studies and
methodological flaws. Thus, as we have outlined in a
recent systematic review [78
&
], most studies that
developed a risk prediction model for psychosis
relied on very small effective sample sizes. This
increases the risk of overfitting and overestimating
the performance of the model, if it is developed and
assessed in the same sample [79]. Furthermore, it can
lead to highly unstable sets of identified predictor
variables. Multicenter studies, which could be a
solution for that, have to struggle hard to overcome
bias from between-center differences and to stand-
ardize their assessments. To achieve the latter,
important initiatives such as ‘HARMONY’ [62] have
been started.
We also found that poor modeling strategies are
widespread [78
&
], for example proper internal vali-
dation was rarely conducted and external validation
studies were completely absent. Fortunately, the
latter has changed recently with the publication
of the first two external validation studies [28,53].
To improve the reliability and clinical usefulness of
newly developed models, future studies should be
conducted in accordance with current checklists
and guidelines on clinical prediction models, such
as the recently published Transparent Reporting of a
Multivariable Prediction Model for Individual Prog-
nosis Or Diagnosis (TRIPOD) [79,80] (for specific
recommendations for prediction of psychosis
research, see also [78
&
]).
Furthermore, the approach of ‘onemodel fits all’
has to be questioned. ‘Psychoses’ are probably a
basket of different illness entities with different
causes and therefore probably also different predic-
tors. Etiological subtyping, however, has so far gener-
ally been quite neglected in psychosis research [81].
A further limitation is the age cutoff. Most stud-
ies only investigate individuals in between 15 and
18 up to 35 years, althoughmany patients have their
onset only later [82,83]. Thus, 10% of men and 20%
of women get first diagnosed after age 40 [84].
Another limitation is the fact that most studies haveHealth, Inc. All rights reserved.
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term studies have, however, shown that there is a
substantial number of conversions after that period
[15–17]. Furthermore, some transitions might be
missed in studies when individuals classified as
‘at risk’ are not seen frequently enough during
follow-ups.
Finally, two major research gaps should be men-
tioned. One is the focus on transition, while recent
research shows that levels of functioning can be
clinically more meaningful than whether an indi-
vidual has actually made the transition to psychosis
or not [85]. Another and probably the most import-
ant point is that translation of research knowledge
into the clinic with broad clinical implementation
is more than incomplete. Obstacles to such a trans-
lation should be examined and worked on. Other-
wise, not many patients will benefit from our
research endeavors.Acknowledgements
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